The biology of glucagon and the consequences of hyperglucagonemia

Research output: Contribution to journalJournal articleResearchpeer-review


The proglucagon-derived peptide hormone, glucagon, comprises 29 amino acids. Its secretion from the pancreatic α cells is regulated by several factors. Glucagon increases blood glucose levels through gluconeogenesis and glycogenolysis. Elevated plasma concentrations of glucagon, hyperglucagonemia, may contribute to diabetes. However, hyperglucagonemia is also observed in other clinical conditions than diabetes, including nonalcoholic fatty liver disease, glucagon-producing tumors and after gastric bypass surgery. Here, we review the current literature on hyperglucagonemia in disease with a particular focus on diabetes, and finally speculate that the primary physiological importance of glucagon may not reside in glucose homeostasis but in regulation of amino acid metabolism exerted via a hitherto unrecognized hepato-pancreatic feedback loop.

Original languageEnglish
JournalBiomarkers in Medicine
Issue number11
Pages (from-to)1141-1151
Number of pages11
Publication statusPublished - 9 Sep 2016

Number of downloads are based on statistics from Google Scholar and

No data available

ID: 165941600